Beta Amyloid Precursor
Beta Amyloid Precursor - Related Videos
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
0 Views •
Cited by 4 •
2021
The present protocol describes an enhanced method to increase the co-expression of PDX1 and NKX6.1 transcription factors in pancreatic progenitors derived from human pluripotent stem cells (hPSCs) in planar monolayers. This is achieved by replenishing the fresh matrix, manipulating cell density, and dissociating the endodermal cells.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
08:01
Stimulation of Notch Signaling in Mouse Osteoclast Precursors
0 Views •
Cited by 13 •
2017
Notch signaling is a form of cellular communication that relies upon direct contact between cells. To properly induce Notch signaling in vitro, Notch ligands must be presented to cells in an immobilized state. This protocol describes methods for in vitro stimulation of Notch signaling in mouse osteoclast precursors.
08:11
Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
0 Views •
Cited by 28 •
2010
We describe a small molecule-based protocol for differentiation of mouse embryonic stem cells into oligodendrocyte precursor cells (OPCs). This protocol generates Olig2+NG2+ OPCs with high efficiency by 30 days of differentiation. We also describe a method to generate "spiking" OPCs that can fire action potentials.
02:59
Light-Activated Treatment of Bacterial Biofilms Using a Photosensitizer Precursor
0 Views •
2026
Source: Zhao, K., et al. An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm. J. Vis. Exp. (2018)The video demonstrates a photodynamic therapy protocol to assess antibacterial effects on Gram-positive bacterial biofilms. Biofilms are divided into four groups: two receive a photosensitizer precursor, and two receive a buffer. All are incubated in the dark, followed by red light exposure to one precursor-treated group and...
FAQs
The initial cleavage determines which downstream fragments can appear. Alpha-secretase and beta-secretase start alternative processing routes, and gamma-secretase then performs a subsequent cleavage. When the beta pathway is used, this sequence releases amyloid-beta peptides; the alpha pathway produces a different fragment pattern. Comparing these routes helps researchers connect enzyme activity with the molecular consequences of APP processing.
The alpha-secretase route provides an essential comparison with beta-secretase processing because the two enzymes initiate different cleavage pathways. This comparison clarifies how APP processing can yield distinct molecular fragments rather than a single fixed product. In neuroscience experiments, examining both routes helps relate enzyme activity to neuronal signaling, synaptic function, and the processes associated with amyloid accumulation.
Gamma-secretase acts after the initial alpha- or beta-secretase event, completing the sequential processing of APP. Its position in the pathway matters because the fragment released depends on which enzyme performed the first cleavage. Studying this second step therefore helps investigators interpret peptide production and understand how processing patterns may relate to neuronal biology and Alzheimer’s disease research.
Useful measurements include secretase activity, peptide production, and clearance. Secretase assays indicate how actively the processing enzymes function, while peptide measurements show the resulting molecular output. Clearance measurements address how those products are removed. Evaluated together, these readouts provide a broader picture of APP metabolism than any single measurement and can support biomarker or therapy studies.
A study can organize analysis around the sequential pathway: assess alpha- and beta-secretase activity, examine the products generated after gamma-secretase cleavage, and measure peptide clearance. Comparing these readouts can reveal whether an experimental condition changes processing or removal. This workflow is relevant to investigations of neuronal maintenance, synaptic function, membrane trafficking, and amyloid accumulation.
APP processing is relevant when researchers investigate molecular events associated with Alzheimer’s disease, particularly amyloid accumulation. Measuring secretase activity and amyloid-beta peptide production can help characterize processing changes, while clearance measurements address removal of the resulting peptides. These data may support biomarker development and the evaluation of therapies designed to target amyloid accumulation.